We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. Find out more Skip to Main Content

Instructions to authors

Please note that this journal is now fully open access and encourages authors to complete their license to publish online. For more information about Open Access licenses and charges, see the “Open Access” section for more information.

The International Journal of Neuropsychopharmacology (IJNP) is the official scientific journal of the Collegium Internationale Neuro-psychopharmacologicum (CINP). IJNP aims to serve as a major forum for the rapid publication and wide dissemination of high quality, influential research in neuropsychopharmacology, in the basic and clinical domains. The central focus of IJNP is on research that (i) advances understanding of existing and new neuropsychopharmacological agents including their mode of action and clinical application, or (ii) provides insights into the biological basis of neuropsychiatric disorders and thereby advances their pharmacological treatment. Such research may derive from the full spectrum of biological and psychological fields of inquiry encompassing classical and novel techniques in neuropsychopharmacology as well as strategies such as neuroimaging, genetics, psychoneuroendocrinology, and neuropsychology. Priority is given to original research that is of wide interest and clearly advances the field.

Editorial policies

Authorship Disclosure Form

All individuals included as authors of papers must have contributed substantially to the scientific process leading up to the writing of the paper. Such contribution includes the conception and design of the project, the performance of experiments and the analysis and interpretation of data. In addition the author should have made a substantial contribution to drafting or critical revision of the manuscript for important intellectual content.

Please note that the Journal now requires that an Authorship Disclosure Form is completed by every author of the manuscript. It is the responsibility of the submitting author to collect the completed forms from all authors and to upload the forms in pdf format via ScholarOne. Papers with missing or incomplete forms will be returned to the author. Therefore, before you start submitting your paper please make sure that you have obtained all the completed forms.

We are aware that authors sometimes receive assistance from technical writers, language editors, and/or writing agencies in preparing manuscripts for publication. Such assistance must be noted in the cover letter and in the Acknowledgements section along with a declaration that the author(s) are entirely responsible for the scientific content of the paper.

Failure to acknowledge assistance from technical writers, language editors, and/or writing agencies in preparing manuscripts for publication in the cover letter and in the Acknowledgements section may lead to disqualification of the paper.

Under no circumstances will IJNP accept submissions by writing or editorial agencies on behalf of authors and there will be no correspondence with writing or editorial agencies regarding submitted or revised manuscripts.

Copyright

To be considered for publication in IJNP, a manuscript cannot have been published previously, nor can it be under review for publication elsewhere. (Previously published figures may be sparingly used in Reviews, with appropriate permission.) The posting of a brief summary of clinical trial outcomes on a pharmaceutical website (such as the PhRMA-sponsored database) will not necessarily count as prior publication nor impede full consideration of a manuscript: IJNP will look at this on a case-by-case basis to determine the extent of overlap between the trial data posted and the manuscript as submitted, and will decide whether the manuscript contains sufficiently new perspectives or sufficient additional data for it to count as original. Authors should declare when submitting manuscripts that such data have already been posted and IJNP will review this.

Papers with multiple authors are reviewed with the assumption that all authors have contributed materially to the research reported, have approved the submitted manuscript, and concur with its submission to IJNP.

All content published in IJNP is made freely available online to all under an Open Access model. See the “Open Access” section below for more information.

Open access

All content published in IJNP is made freely available online to all under an Open Access model.

After a manuscript is accepted for publication, the corresponding author will be required to accept a mandatory license to publish agreement. RCUK/Wellcome Trust funded authors can use the Creative Common Attribution license (CC BY) for their articles. All other authors should use the Creative Commons Attribution Non-Commercial license (CC BY-NC).

More information about the Creative Commons licenses.

Paying the open access charge means that the author retains copyright of the paper; the article will be made freely available to all readers. Open Access allows the author free use of the article with respect to distribution, permission to reuse figures, and archiving online. For more information on Open Access, please go here: http://www.oxfordjournals.org/en/help/faq/oxford-open.html

Charges for CC BY-NC license:

  • Regular charge for CINP members: £1000, $1500, €1200
  • Regular charge for non-CINP members: £1400, $2200, €1700
  • List B Developing country charge*: £700, $1100, €850
  • List A Developing country charge*: £0 /$0 / €0

Charges for CC BY license:

  • Regular charge for CINP members: £1000, $1500, €1200
  • Regular charge for non-CINP members: £1400, $2200, €1700
  • Reduced Rate Developing country charge*: £700, $1100, €850
  • Free Developing country charge *: £0 /$0 / €0

*Click here for a list of qualifying countries.

Visit http://cinp.org/membership/ to become a member of CINP.

You can pay Open Access charges using our Author Services site. This will enable you to pay online with a credit/debit card or to request an invoice by email or post. The applicable Open Access charges vary according society membership status of the corresponding author and which Creative Commons license the authors select.

Orders from the UK will be subject to the current UK VAT charge. For orders from the rest of the European Union, OUP will assume that the service is provided for business purposes. Please provide a VAT number for yourself or your institution, and ensure your account for your own local VAT correctly.

Clinical Trials

As a condition of consideration for publication, registration of clinical trials in a public trials registry is required. A clinical trial is defined by the International Committee of Medical Journal Editors (in accordance with the definition of the World Health Organization) as any research project that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes. Trials must be registered before the start of patient enrollment. The registry must be accessible to the public at no charge. It must be open to all prospective registrants and managed by a not-for-profit organization. There must be a mechanism to ensure the validity of the registration data, and the registry should be electronically searchable. An acceptable registry must include at minimum a unique trial number, trial registration date, secondary identification information if assigned by sponsors or others, funding source(s), primary and secondary sponsor(s), responsible contact person, research contact person, official scientific title of the study, research ethics review, the medical condition being studied, intervention(s), key inclusion and exclusion criteria, study type, anticipated trial start date, target sample size, recruitment status, primary outcome, and key secondary outcomes. Registration information must be provided at the time of submission. Trial registry name, registration identification number, and the URL for the registry should be included at the end of the abstract.

Manuscripts reporting the results of randomized controlled trials need to include a "CONSORT" flow diagram as a figure in the manuscript to illustrate the progress of all patients in the study (See: Schulz KF, Altman D, for the CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001;285(15):1987-1991.)

Ethical Considerations

Papers reporting experiments involving human subjects must contain the statement that the research was approved by an Internal Review Board, Helsinki Committee, or similar body and that subjects gave informed consent. Papers describing animal experiments must indicate that the research was approved by a Review Committee or clearly state that the experiments were performed in accordance with accepted guidelines such as "Guiding principles in the care and use of animals" (DHEW Publications, NIH, 80-23). Papers that do not contain an Ethics Statement will not be reviewed.

Review Process

Manuscripts submitted to IJNP including those for supplements will be reviewed by at least two external reviewers and evaluated by a Field Editor. Authors are required to suggest a minimum of 4 reviewers who are especially qualified to referee the work and would not have a conflict of interest. Please provide the first and second names, email addresses, institution or affiliation, and phone number of the suggested reviewers. If authors would prefer that a particular reviewer(s) not evaluate the paper, they may indicate this request in the cover letter, which will be treated confidentially. Suggestions and requests regarding reviewers will be considered by the Editor without obligation to accept them.

Authors should note that manuscripts might be returned after initial review by the Editors if the paper is deemed unlikely to be reviewed favorably. This rapid rejection process enables the author to submit promptly for publication elsewhere.

Every effort will be made to provide the author with a review within 6 weeks of receipt of the manuscript. For Rapid Communications the target review time is 3 weeks. If the Editor requests that minor revisions be made to a manuscript these should be resubmitted within 30 days. A maximum of 90 days shall be allowed for preparation of major revisions, except in unusual circumstances.

Self-Archiving

Under the terms of the license, authors are entitled to deposit the final published version of their article in institutional and/or centrally organized repositories immediately upon publication, provided that the journal and OUP are attributed as the original place of publication and that correct citation details are given. Authors are also strongly encouraged to deposit the URL of their published article, in addition to the PDF version.

NIH, HHMI, UK MRC, and Wellcome Trust grantees should note that OUP automatically deposits all Open Access articles in PMC and UKPMC, where they are made freely available immediately upon publication in an issue of the journal. This means that all articles published in IJNP are fully compliant with the NIH Public Access policy and the HHMI, UK MRC, and Wellcome Trust policies on Open Access; therefore, authors wishing to comply with these policies need not take further action. For example, a separate submission to the NIHMS system is not necessary for authors (see http://nihms.nih.gov/faq.html for confirmation of this). Because IJNP is fully Open Access, immediately upon publication of the final version of the article, OUP will upload the article automatically to PubMed Central.

Manuscript preparation

All manuscripts are submitted and reviewed via the journal's web-based manuscript submission system. New authors should create an account prior to submitting a manuscript for consideration.

Manuscripts submitted to The International Journal of Neuropsychopharmacology should be prepared following the American Medical Association Manual of Style, 10th edition. The manuscript text (including tables) should be prepared using a word processing program and saved as an .rtf or .doc file. Other file formats will not be accepted. Figures must be saved as individual .tif files and should be numbered consecutively (i.e., Figure 1.tif, Figure 2.tif, etc.). The text must be double-spaced throughout and should consist of the sections described below.

Language Editing

Non-native English speakers may wish to have their manuscript professionally edited prior to submission. While language editing does not guarantee that your paper will be accepted for publication, it may help to ensure that its academic content is fully understood by journal editors and reviewers. Authors are liable for all costs associated with the use of these services.

Categories of Papers

Note: Letters to the Editor are accepted but we will no longer accept Case Reports

Regular research articles - This category is intended for full-scale basic or clinical studies including large controlled trials. Articles may contain up to 5,000 words (not including references, figures, and tables) and should include an abstract of up to 250 words, and 3–5 key words. (Exceptions to the length limitation will be considered for unusually large or complex studies.)

Brief reports/clinical reports - This category is for smaller, self-contained laboratory or clinical studies including series of cases illustrating a novel therapeutic approach or clinical observation, or alerting readers to important adverse drug effects. (Single cases will not be considered in this category and should be submitted as Letters to the Editor.) Papers in this category may contain up to 2,500 words (not including references, figures, and tables) and should include a maximum of 25 references, up to 2 illustrations (figures or tables), an abstract of up to 150 words, and 3–5 key words.

Rapid communications - This category is for 'fast-breaking' new work, which is of great potential interest and can be succinctly presented.
Authors who wish to submit a rapid communication must first send an abstract to the Editor-in-Chief, Alan Frazer (frazer@uthscsa.edu) for approval of submission in this category. Submissions that do not have prior approval will be reviewed on the regular track.
Papers in this category may contain up to 2,500 words (not including references, figures, and tables) and should include a maximum of 25 references, up to 2 illustrations (figures or tables), an abstract of up to 150 words and 3–5 key words. Rapid communications will be reviewed on a “fast track” basis.

Reviews - IJNP will publish a limited number of scholarly, comprehensive reviews that summarize and critically evaluate research in the field, addressing and identifying future implications. Reviews will be invited by the Editors but may also be submitted. Authors wishing to submit papers in this category should contact the Editor-in-Chief before doing so. Reviews may contain up to 5,000 words (not including references, figures and tables) and should include an abstract of up to 250 words, and 3–5 key words. (Exceptions to the length limitation will be considered if justified by the scope of the Review).

Trends and perspectives - Papers in this section provide readers of IJNP with focused coverage of topical issues in neuropsychopharmacology and related disciplines which are of high current interest and potential. Hypothesis and Opinion papers, Updates, Commentaries, and Notes on New Techniques will also be included. Articles of this type will be invited but may also be submitted. Papers in this section may contain up to 2500 words and should include an abstract of up to 150 words and 3–5 key words. Authors wishing to submit articles for this section are asked to consult with the Editor-in-Chief or appropriate Field Editor.

Letters to the editor - These should briefly report single experiments and cases of clinical interest or respond to recent articles in IJNP. The body of the Letter may contain a maximum of 1,000–1,500 words plus one Figure or Table and up to 10 references. IJNP no longer accepts case reports.

Focus papers – These papers focus attention on a research paper published in the same issue in the journal. Focus Papers should highlight, discuss, and amplify the issues addressed in the research paper adding perspectives derived from the author’s own work and the literature and should consider the implications of the findings. Focus papers need not necessarily agree with the paper they address. Focus Papers may contain up to 1,500 words (not including references, figures, and tables) and 3–5 key words. No abstract is needed. Focus Papers are invited by the Editor-in-Chief.

Papers in all categories, whether invited or submitted, will be peer reviewed.

Title Page

The Title Page should contain the full titles of the manuscript, the category under which the manuscript is submitted, the full names, degrees, and affiliations of all authors, a contact name and address with telephone number, fax number and electronic mail address (if available) for the corresponding author, and a Statistical Summary containing the Word Count of the abstract and the body of the manuscript (separately), the number of references and the number of figures and tables.

We would appreciate your keeping your article title simple to enhance its discoverability of the article in Google searches.

Please note that unless permission is requested in advance for more than one corresponding author, only one corresponding author should be indicated.

Significance Statement (150 words maximum)

The significance statement should provide an explanation of the importance of the research. This should be done succinctly and in “lay” language. The Significance Statement will appear within the paper. The inclusion of this statement is only applicable for research articles. 

Abstract

The Abstract (page 2) should be structured and should provide the reader with a self-contained summary of the paper. Abstracts should be 250 words or less, structured with sections entitled as follows: Background, Methods, Results, and Conclusions.

Main Text

The Body of the Manuscript should begin on page 3. For Regular Research Articles, Brief and Clinical Reports, and Rapid Communications, the format should include: Introduction, Method, Results, Discussion, and Acknowledgments. These should be followed on a new page by the References. The use of Abbreviations, except those that are widely used, is strongly discouraged. They should be used only if they contribute to better comprehension of the manuscript. Acronyms should be spelled out at first mention. Metric system (SI) units should be used.

IJNP encourages submissions from all over the world. Authors who are not fluent in written English are encouraged to seek assistance in this regard before submitting their manuscripts.

Funding

Details of all funding sources for the work in question should be given in a separate section entitled 'Funding'. This should appear before the 'Acknowledgments' section.

The following rules should be followed:

  • The sentence should begin: ‘This work was supported by …’
  • The full official funding agency name should be given, i.e. ‘the National Cancer Institute at the National Institutes of Health’ or simply 'National Institutes of Health', not 'NCI' (one of the 27 subinstitutions) or ‘NCI at NIH’ (full RIN-approved list of UK funding agencies) .
  • Grant numbers should be complete and accurate and provided in parentheses as follows: ‘(grant number xxxx)’.
  • Multiple grant numbers should be separated by a comma as follows: ‘(grant numbers xxxx, yyyy)’.
  • Agencies should be separated by a semi-colon (plus ‘and’ before the last funding agency).
  • Where individuals need to be specified for certain sources of funding the following text should be added after the relevant agency or grant number 'to [author initials]'.
  • An example is given here: ‘This work was supported by the National Institutes of Health (P50 CA098252 and CA118790 to R.B.S.R.) and the Alcohol & Education Research Council (HFY GR667789).'

Crossref Funding Data Registry

In order to meet your funding requirements authors are required to name their funding sources, or state if there are none, during the submission process. For further information on this process or to find out more about the CHORUS initiative please click here.

Acknowledgments

In this section authors should acknowledge support for the work that is reported in the paper from granting agencies and other sources. This is particularly important in the case of research that is supported by industry. Support from industry not only includes direct financial support for the study but also support in kind such as provision of medications, equipment, kits, or reagents without charge or at reduced cost and provision of services such as statistical analysis. The contribution of individuals who assisted with the research but are not included as authors of the paper may be acknowledged in this section.

The Acknowledgments should be placed after the main body of the text before the references. If there are no Acknowledgments, the title should be inserted followed by “None”. Papers that do not include an Acknowledgment section will not be reviewed.

Conflict of Interest

Conflict of interest exists when an author has interests that might inappropriately influence his or her judgement, even if that judgement is not influenced. Because of this, authors must disclose potentially conflicting interests so that others can make judgments about such effects. At the time of submission authors should disclose any financial arrangements or connections they may have that are pertinent to the submitted manuscript and that may be perceived as potentially biasing their paper. Non-financial interests that could be relevant in this context should also be disclosed. If no relevant interests exist, this should be stated. This requirement applies to all the authors of a paper and to all categories of papers including letters to the editor. Authors may consult with the Editor-in-Chief regarding material to be included in this disclosure (by email to frazer@uthscsa.edu). Such consultation will be held in strict confidence. All submissions must contain a Statement of Interest.
The Statement of Interest should be placed after the Acknowledgements before the references. If there are no interests to declare, the title should be inserted followed by “None”.
Papers that do not include a Statement of Interest will not be reviewed.

Supplementary Material

The online platform gives authors the opportunity to include data that would be impossible or impractical to include in the printed version. These data might substantially enhance the importance of the research and might also be of benefit to readers. Authors may include tables and figures as well as data such as videos, 3-D structures/images, extensive datasets and any other supplementary material not suitable for print duplication. All supplementary material must be submitted with the original manuscript. Supplementary data should be referred to in the text with the prefix "S" (e.g. Supplementary Table S1, Supplementary Figure S1). Supplementary files will not be copy-edited, and will be published as supplied.

References

The style is that used by the Journal of Neuroscience. All software packages for references, e.g., EndNote, Reference Manager, etc. have this style.

Reference Style Instructions:
Only references that have been published or are "in press" (i.e. accepted for publication in a specific journal or book) should appear in the reference list at the end of the paper. The most up to date information on references that are "in press" is to be provided. References that have been submitted for publication but are not yet in press should be cited only in text and in the following form: (A. B. Thomson, C. R. Johnson, and F. Lewis, unpublished observations). The form for personal communications is similar: (R. P. Smith, personal communication). Responsibility for all personal communications lies with the author(s) and authors must obtain written approval from persons cited before submitting the paper to IJNP. Proof of such approval may be requested by IJNP.

In text References: References should be cited in the text as follows: "The procedure used has been described elsewhere (Brown, 1998),"or "Our observations are in agreement with those of Reid and Malik (1986) and of Smythe et al. (2000),"or with multiple references, in chronological order: "Earlier reports (Brown and Connors, 1999, 2001; White et al., 2000; Smythe, 2002, 2004).... "

List of References: (to be typed double-spaced) Papers should be listed in alphabetical order according to the surname of the first author. In two-author papers with the same first author, the order is alphabetical by the second author's name. In three-or-more-author papers with the same first author, the order is chronological. The name of the author(s) should be followed by the date in parentheses, the full title of the paper as it appeared in the original together with the source of the reference, the volume number, and the first and last pages. Do not number or bullet the references. If the author list for a paper in the references exceeds 20, the paper should be cited as Author A et al. The following illustrate the format to be used:

Journal article
Helms G, Dathe H, Dechent P (2008a) Quantitative FLASH MRI at 3T using a rational approximation of the Ernst equation. Magn Reson Med 59:667– 672.

Helms G, Dathe H, Kallenberg K, Dechent P (2008b) High-resolution maps of magnetization transfer with inherent correction for RF inhomogeneity and T1 relaxation obtained from 3D FLASH MRI. Magn Reson Med 60:1396 –1407.

Jung RE, Haier RJ (2007) The parieto-frontal integration theory (P-FIT) of intelligence: converging neuroimaging evidence. Behav Brain Sci 30:135–154, discussion 154–187.

Gellerich FN, Gizatullina Z, Trumbeckaite S, Nguyen HP, Pallas T, Arandarcikaite O, Vielhaber S, Seppet E, Striggow F (2010) The regulation of OXPHOS by extramitochondrial calcium. Biochim Biophys Acta 1797:1018 –1027.

Ichord RN, Johnston MV, Traystman RJ (2001) MK801 decreases glutamate release and oxidative metabolism during hypoglycemic coma in piglets. Brain Res Dev Brain Res 128:139 –148.

Pellerin L, Magistretti PJ (2011) Sweet sixteen for ANLS. J Cereb Blood Flow Metab. Advance online publication. Retrieved 26 Oct 2011. doi: 10.1038/jcbfm.2011.149.

Book
Yarkoni T, Braver T, Szymura E (2010) Cognitive neuroscience approaches to individual differences in working memory and executive control: conceptual and methodological issues. Handbook of individual differences in cognition: Attention, memory and executive control. New York: Springer.

Chapter in a book
Stent GS (1981) Strength and weakness of the genetic approach to the development of the nervous system. In: Studies in developmental neurobiology: essays in honor of Viktor Hamburger (Cowan WM, ed), pp288-321. New York: Oxford UP.

Please consult the Index Medicus for the correct abbreviations of journal titles. The author(s) are wholly responsible for the correctness of the references. After manuscript revisions, authors should double-check that all in-text citations are in the reference list and that all references on the reference list have at least one corresponding in-text citation. Failure to do so will result in a delay in the proofing stage and possibly a delay in publication.

Figures and Tables

Tables should be consecutively numbered as they appear in the text (Table 1, etc.). Each Table should be typed on a separate sheet with the Table number and heading above, and any note below.
Figures should be consecutively numbered as they appear in the text (Figure 1, 2 etc). Use italic letters for parts a, b, c etc. Use abbreviation (Fig), except where starting a new sentence. Legends should be provided for each Figure. Scale bars should be added to photomicrographs and other similar images.

Tables should be created with the table function of a word processing program; spreadsheets are not acceptable. Include only essential data, and format the table in a manner in which it should appear in the text. Each table must fit on a single manuscript page and have a short title that is self-explanatory without reference to the text. Footnotes can be used to explain any symbols or abbreviations appearing in the table. Do not duplicate data in tables and figures. Tables should be placed at the end of the document and not within the text.

Please supply figures as .tif  or .eps files (1200 d.p.i. for line drawings and 300 d.p.i. for color and half-tone artwork). Maximum file size should be 80MB. Figure legends should be typed separately from the figures in the main text document. Additional information on preparing your figures for publication can be located at the digital art website.

Wherever possible figures should be submitted in their desired final size, to fit the width of a single (88 mm) or at most a double (180 mm) column width. All letters and numerals appearing in a particular figure should be of the same size and in proportion to the overall dimensions of the drawing. Letter labels used in figures should be in upper case in both the figure and the legend. The journal reserves the right to reduce the size of illustrative material.

Each figure should have a separate legend that clearly identifies all symbols and abbreviations used. The legend should be concise and self-explanatory and should contain enough information to be understood without reference to the text.

Note: All tables and figures reproduced from a previously published manuscript must cite the original source (in the figure legend or table footnote) and be accompanied by a letter of permission from the publisher of record or the copyright owner.

Proofs

Page proofs will be sent to the corresponding author by e-mail as an Acrobat PDF file. The software needed to view this type of file can be downloaded at no charge from the Adobe website. Please check text, tables, legends, and references carefully. Proofs must be returned within two days of receipt. The editors and publisher reserve the right to proceed with publication if this period is exceeded. Only typographical errors can be corrected at this stage; substantial changes to the text will not be accepted.

License to publish form

Upon receipt of accepted manuscripts at Oxford Journals authors will be invited to complete an online license to publish form.

Please note that by submitting an article for publication you confirm that you are the corresponding/submitting author and that Oxford University Press ("OUP") may retain your email address for the purpose of communicating with you about the article. You agree to notify OUP immediately if your details change. If your article is accepted for publication OUP will contact you using the email address you have used in the registration process. Please note that OUP does not retain copies of rejected articles.

Permissions for illustrations and figures

In order to reproduce any third party material, including figures or tables, in an article authors must obtain permission from the copyright holder and be compliant with any requirements the copyright holder may have pertaining to this reuse.

When seeking to reproduce any kind of third party material authors should request the following:

  1. non-exclusive rights to reproduce the material in the specified article and journal;
  2. electronic rights, preferably for use in any form or medium;
  3. the right to use the material for the life of the work; and
  4. world-wide English-language rights.

Further guidelines on clearing permissions.

Authors should also include a statement indicating that permission has been obtained in the relevant legend/footnote and provide the Editorial Office with copies of any relevant paperwork.

A template permissions request letter can be found at the end of the above document.

Manuscript submission instructions

Getting Help

If you experience any problems during the online submission process please consult the Author's User Guide which provides more detailed submission instructions and 'movie tutorials' explaining how to submit your paper. Alternatively, please contact the Journal's Editorial Office who will be pleased to assist you. All manuscripts are submitted and reviewed via ScholarOne Manuscripts. New authors should create an account prior to submitting a manuscript for consideration.

Preparing Your Manuscript

  1. Follow the manuscript preparation instructions to authors regarding the format of your manuscript and references.
  2. Prepare your manuscript, including tables, using a word processing program and save it as a .doc or .rtf file. All files in these formats will be converted to .pdf format upon submission.
  3. Prepare your figures at publication quality resolution, using applications capable of generating high-resolution .tif files (1200 d.p.i. for line drawings and 300 d.p.i. for color and half-tone artwork). The printing process requires your figures to be in this format if your paper is accepted and printed. For useful information on preparing your figures for publication, go to http://cpc.cadmus.com/da. Prepare any other files that are to be submitted for review, including any supplementary material. The permitted formats for these files are the same as for manuscripts and figures. Other file types, such as Microsoft Excel spreadsheets and PowerPoint presentations, may be uploaded and will form part of the single PDF proof that is created for use in the peer review process. It is also possible to upload TeX and LaTeX files but these will not be automatically converted to .pdf format (and are therefore discouraged). The journal staff, editors, and reviewers will only be able to view these unconverted files if they have the appropriate software, which cannot be guaranteed.
  4. When naming your files, please use simple file names and avoid special characters and spaces. If you are a Macintosh user, you must also ensure that the three-letter extension appears at the end of the file name you choose (e.g. .doc, .rtf, .jpg, .gif, .tif, .ppt, .xls, .pdf, .eps, .mov).
  5. The online submission software, ScholarOne Manuscripts, will automatically create a single PDF document containing your main text and reduced-resolution versions of any figures and tables you have submitted. This document will be used when your manuscript undergoes peer review. Your submitted files will appear in this PDF sequentially, as specified by you on the submission page, and you will have an opportunity to enter figure captions/legends and to check the PDF proof prior to final submission.

Submitting Your Manuscript

Now that your files are ready, visit the online submission website.

  1. First, you will need to log into the system. Note: Before you begin, you should be sure you are using an up-to-date version of Netscape or Internet Explorer. If you have an earlier version, you can download a free upgrade using the icons found at the bottom of the 'Instructions and Forms' section of the online submission website.
    • If you know your log-in details (i.e., you have submitted or reviewed a manuscript on this system before), use your User ID and Password to log on.
    • If you do not know your log-in details, check to see if you are already registered by clicking on the 'Forgot your Password' button and following the on-screen instructions. If you are not already registered, you can register by clicking on the 'Create Account' button on the log-in screen and following the on-screen instructions.
    • If you have trouble finding manuscripts or have other problems with your account do not create another account. Instead, please contact the Journal's Editorial Office.
  2. To submit a new manuscript, go to the 'Author Centre', click on the button to 'Submit a Manuscript', and then follow the on-screen instructions. There are up to 7 steps for you to follow to submit your manuscript. You move from one step to the next by clicking on the 'Save and Continue' button on each screen or back to the previous screen by clicking on the 'Previous' button. Please note that if you click on the 'Back' or 'Forward' button on your browser, the information you have entered will not be saved. At any stage you can stop the submission process by clicking on the 'Main Menu' button. Everything you have typed into the system will be saved, and the partially completed submission will appear under 'unsubmitted manuscripts' in your 'Author Centre'. To return to the submission process you will need to click on the button 'Continue Submission' against the relevant manuscript title.
  3. When submitting your manuscript, please enter your manuscript data into the relevant fields, following the detailed instructions given at the top of each page. You may like to have the original word processing file available so that you can copy and paste the title and abstract into the required fields. You will also be required to provide e-mail addresses for your co-authors, so please have these to hand when you log into the site.
  4. When you come to upload your manuscript files via the 'File Upload' screen:
    • Enter individual files using the 'Browse' buttons below and select the appropriate 'File content' type.
    • Select the document's designation from the pull-down menu. The designation choices may vary, but will always include 'Main Document' (your manuscript text). If you do not wish a document to be included as part of the consolidated PDF used for peer review, please designate it as a 'supplementary file'.
    • Upload your files by clicking on the 'Upload files' button. This converts your files to a PDF and may take several minutes. Repeat these steps until you have uploaded all your files.
    • When the upload of each file is completed, you will see a confirmation window and be prompted to provide figure legends and 'file tags' that will link figures to texts in the HTML proof of your main document.
    • Once you have uploaded all files, indicate the order in which they should appear in your paper. This will determine the order in which they appear in the consolidated PDF used for peer review.
    • After the successful upload of your text and images, you will need to view and proof your manuscript. Please do this by clicking on the blue HTML button or a PDF button.
    • If the files have not been uploaded to your satisfaction, go back to the file upload screen where you can remove the files you do not want, and repeat the upload process.
  5. When you are satisfied with the uploaded manuscript proof click on 'Next' which will take you to the 'Review & Submit' screen. The system will check that you have completed all the mandatory fields and that you have viewed your manuscript proof. It will also present you with a summary of all the information you have provided and give you a final chance to edit it. When you have finished reviewing this information press 'Submit'.
  6. After the manuscript has been submitted you will see a confirmation screen and receive an e-mail confirmation stating that your manuscript has been successfully submitted. This will also give the assigned manuscript number, which is used in all correspondence. If you do not receive this, your manuscript will not have been successfully submitted to the journal and the paper cannot progress to peer review. If this is the case your manuscript will still be sitting in the 'Unsubmitted Manuscripts' section of your 'Author Centre' awaiting your attention.
  7. If you return to your 'Author Centre' you will notice that your newly submitted manuscript can be found in the 'Submitted Manuscripts' area. Among the information listed there, the 'Processing Status' section provides information on the status of your manuscript as it moves through the review process.

Submitting a Revised Manuscript

Please supply your revised paper though the online submission website using your User ID and Password to log on--remembering that these are both case-sensitive.

  1. Log on to the online submission website and, in the 'Author Centre', click on Manuscripts with Decisions under 'My Manuscripts'. You will then see a list of all manuscripts you have submitted where the editors have been able to make a decision.
  2. Find the manuscript you wish to revise and click on the link 'create a revision' in the 'Actions' column.
  3. This will initiate a revised-submission process that prompts you to respond to the points made by the Editors and/or reviewers.
  4. Continue to follow the 7-step submission process, providing information when prompted.

Please note: All the files from your previous submission will have been retained by the system. So, when your reach the 'File Upload' screen (Step #6), you will need to delete any files that are no longer needed or need replacing with revised versions.

IMPORTANT. As detailed above, your images are required as high-resolution .tif files (1200 d.p.i. for line drawings and 300 d.p.i. for color and half-tone artwork). For useful information on preparing your figures for publication, go to the digital art website. Please note that publication of your manuscript will not proceed until figures suitable for reproduction are received.

Supplementary Material

Supplementary material can be made available by the publisher as online-only content, linked to the online manuscript.

Definition: Supporting material that cannot be included in the printed version for reasons of space, and that is not essential for inclusion in the full text of the manuscript, but would nevertheless benefit the reader. It should not be essential to understanding the conclusions of the paper, but should contain data that is additional or complementary and directly relevant to the article content.

Examples: More detailed methods, extended data sets/data analysis, tables, or additional figures (including color).

Process: All material to be considered as supplementary material must be submitted at the same time as the main manuscript for peer review. Please indicate clearly the material intended as supplementary material during online submission. Also ensure that the supplementary material is referred to in the main manuscript at an appropriate point in the text. It cannot be altered or replaced after the paper has been accepted for publication. Supplementary material should be submitted online, in its final form.

Please note that supplementary material will not be edited, so ensure that it is clearly and succinctly presented, and that the style of terms conforms with the rest of the paper. Also ensure that the presentation will work on any internet browser.

Acceptable formats: A maximum of 10 files is acceptable to make up the supplementary material unit for the article. The maximum size per file should not exceed 1.5 MBytes, and files must be as small as possible, so that they can be downloaded quickly.

Recommendations:

  1. Pick a common cross-platform (PC, Mac, Linux/UNIX, Amiga etc.) format for your supplementary material to allow the greatest access.
  2. Provide text files in PDF (.pdf), MS Word (.doc), HTML files (.html) or RTF (.rtf) format. Files supplied in Word or RTF may be used to createa PDF file.
  3. Provide spreadsheet files in MS Excel (.xls) or CSV format.
  4. Provide image files in .tif, .gif or .jpg format. Images should be a maximum size of 640 x 480 pixels (9 x 6.8 inches at 72 pixels per inch).
  5. Provide sound clips in .mp3 format.
  6. Provide movie clips in .mpg format.

If you require further help or information regarding submission or preparation of supplementary material, please contact the Oxford Journals production department.

 

To sign up for IJNP eTOC/Advance Access alerts:

  1. Go here: http://ijnp.oxfordjournals.org/
  2. Scroll down the page to where it says “Alert services,” where it gives you the opportunity to sign up for eTOC alerts and advance access alerts.
  3. After the eTOC page appears there is a listing of subjects. Select “Medicine” and then scroll to International Journal of Neuropsychopharmacology and click the two squares next to it.
  4. Press the confirm or save button.
  5. For Advance Access alerts (notifications of articles that appear online prior to appearing in an issue eTOC), complete the same steps
This Feature Is Available To Subscribers Only

Sign In or Create an Account

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Subscribe Now